Cargando…

Recommendations for the conduct of clinical trials for drugs to treat or prevent sarcopenia

PURPOSE: Sarcopenia is an age-related muscle condition which is frequently a precursor of frailty, mobility disability and premature death. It has a high prevalence in older populations and presents a considerable social and economic burden. Potential treatments are under development but, as yet, no...

Descripción completa

Detalles Bibliográficos
Autores principales:	Reginster, Jean-Yves, Cooper, Cyrus, Rizzoli, René, Kanis, John A., Appelboom, Geoff, Bautmans, Ivan, Bischoff-Ferrari, Heike A., Boers, Maarten, Brandi, Maria Luisa, Bruyère, Olivier, Cherubini, Antonio, Flamion, Bruno, Fielding, Roger A., Gasparik, Andrea Ildiko, Van Loon, Luc, McCloskey, Eugene, Mitlak, Bruce H., Pilotto, Alberto, Reiter-Niesert, Suzanne, Rolland, Yves, Tsouderos, Yannis, Visser, Marjolein, Cruz-Jentoft, Alfonso J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2015
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4768478/ https://www.ncbi.nlm.nih.gov/pubmed/26717937 http://dx.doi.org/10.1007/s40520-015-0517-y

Ejemplares similares

Sarcopenia in daily practice: assessment and management
por: Beaudart, Charlotte, et al.
Publicado: (2016)

Pitfalls in the measurement of muscle mass: a need for a reference standard
por: Buckinx, Fanny, et al.
Publicado: (2018)

Validation of the SarQoL®, a specific health‐related quality of life questionnaire for Sarcopenia
por: Beaudart, Charlotte, et al.
Publicado: (2016)

Assessment of health claims in the field of bone: a view of the Group for the Respect of Ethics and Excellence in Science (GREES)
por: Bruyère, O., et al.
Publicado: (2011)

The Authors reply: “Dual energy X‐ray absorptiometry: gold standard for muscle mass?” by Scafoglieri et al.
por: Buckinx, Fanny, et al.
Publicado: (2018)

The authors reply: Letter on: “Pitfalls in the measurement of muscle mass: a need for a reference standard” by Clark et al.
por: Buckinx, Fanny, et al.
Publicado: (2019)

Intervention thresholds and diagnostic thresholds in the management of osteoporosis
por: Kanis, John A., et al.
Publicado: (2022)

Vitamin D supplementation in the prevention and management of major chronic diseases not related to mineral homeostasis in adults: research for evidence and a scientific statement from the European society for clinical and economic aspects of osteoporosis and osteoarthritis (ESCEO)
por: Cianferotti, Luisella, et al.
Publicado: (2017)

European guidance for the diagnosis and management of osteoporosis in postmenopausal women
por: Kanis, J. A., et al.
Publicado: (2012)

Measuring health-related quality of life in sarcopenia: summary of the SarQoL psychometric properties
por: Beaudart, Charlotte, et al.
Publicado: (2023)

Development of a self-administrated quality of life questionnaire for sarcopenia in elderly subjects: the SarQoL
por: Beaudart, Charlotte, et al.
Publicado: (2015)

Can We Identify Patients with High Risk of Osteoarthritis Progression Who Will Respond to Treatment? A Focus on Biomarkers and Frailty
por: Arden, Nigel, et al.
Publicado: (2015)

Algorithm for the Use of Biochemical Markers of Bone Turnover in the Diagnosis, Assessment and Follow-Up of Treatment for Osteoporosis
por: Lorentzon, Mattias, et al.
Publicado: (2019)

Sarcopenia: burden and challenges for public health
por: Beaudart, Charlotte, et al.
Publicado: (2014)

Effects of vitamin D in the elderly population: current status and perspectives
por: Bruyère, Olivier, et al.
Publicado: (2014)

Burden of frailty in the elderly population: perspectives for a public health challenge
por: Buckinx, Fanny, et al.
Publicado: (2015)

Evaluation of symptomatic slow-acting drugs in osteoarthritis using the GRADE system
por: Bruyère, Olivier, et al.
Publicado: (2008)

How clinical practitioners assess frailty in their daily practice: an international survey
por: Bruyère, Olivier, et al.
Publicado: (2017)

Health Technology Assessment in Osteoporosis
por: Hiligsmann, Mickael, et al.
Publicado: (2013)

Publication outcomes of the abstracts presented at the 2011 European Congress on Osteoporosis, Osteoarthritis and Musculo-Skeletal Diseases (ECCEO-IOF11): A position paper of the European Society for Clinical and Economical Aspects of Osteoporosis, Osteoarthritis and Musculo-Skeletal Diseases (ESCEO) and the International Osteoporosis and Other Skeletal Diseases Foundation (IOF)
por: Rabenda, Véronique, et al.
Publicado: (2015)

Unmet needs and current and future approaches for osteoporotic patients at high risk of hip fracture
por: Ferrari, Serge, et al.
Publicado: (2016)

Diacerein: Benefits, Risks and Place in the Management of Osteoarthritis. An Opinion-Based Report from the ESCEO
por: Pavelka, Karel, et al.
Publicado: (2016)

Sarcopenia and health‐related quality of life: A systematic review and meta‐analysis
por: Beaudart, Charlotte, et al.
Publicado: (2023)

Inappropriate claims from non-equivalent medications in osteoarthritis: a position paper endorsed by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO)
por: Bruyère, Olivier, et al.
Publicado: (2017)

The prevention of fragility fractures in patients with non-metastatic prostate cancer: a position statement by the international osteoporosis foundation
por: Cianferotti, Luisella, et al.
Publicado: (2017)

Nutritional Status and Nutritional Treatment Are Related to Outcomes and Mortality in Older Adults with Hip Fracture
por: Malafarina, Vincenzo, et al.
Publicado: (2018)

European guidance for the diagnosis and management of osteoporosis in postmenopausal women
por: Kanis, J.A., et al.
Publicado: (2018)

Correction to: European guidance for the diagnosis and management of osteoporosis in postmenopausal women
por: Kanis, J.A., et al.
Publicado: (2020)

Vitamin D and osteosarcopenia: an update from epidemiological studies
por: Bruyère, Olivier, et al.
Publicado: (2017)

Update on the role of pharmaceutical-grade chondroitin sulfate in the symptomatic management of knee osteoarthritis
por: Honvo, Germain, et al.
Publicado: (2019)

Health Economic Evaluation of a High and Low Molecular Weight Hyaluronic Acid Formulation for the Treatment of Knee Osteoarthritis. Post Hoc Analyses from a Randomized Clinical Trial
por: Bruyère, Olivier, et al.
Publicado: (2022)

Health Technology Assessment of Different Glucosamine Formulations and Preparations Currently Marketed in Thailand
por: Bruyère, Olivier, et al.
Publicado: (2023)

Can We Identify Patients with High Risk of Osteoarthritis Progression Who Will Respond to Treatment? A Focus on Epidemiology and Phenotype of Osteoarthritis
por: Bruyère, Olivier, et al.
Publicado: (2015)

Role of vitamin D supplementation in the management of musculoskeletal diseases: update from an European Society of Clinical and Economical Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) working group
por: Chevalley, Thierry, et al.
Publicado: (2022)

Value of biomarkers in osteoarthritis: current status and perspectives
por: Lotz, M, et al.
Publicado: (2013)

Republished: Value of biomarkers in osteoarthritis: current status and perspectives
por: Lotz, M, et al.
Publicado: (2014)

Identification and management of patients at increased risk of osteoporotic fracture: outcomes of an ESCEO expert consensus meeting
por: Kanis, J. A., et al.
Publicado: (2017)

Smart wearable body sensors for patient self-assessment and monitoring
por: Appelboom, Geoff, et al.
Publicado: (2014)

Effects of Dairy Products Consumption on Health: Benefits and Beliefs—A Commentary from the Belgian Bone Club and the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases
por: Rozenberg, Serge, et al.
Publicado: (2015)

Vitamin D inadequacy in Belgian postmenopausal osteoporotic women
por: Neuprez, Audrey, et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_a2drbl98ipo1o2ctqdn10o87ef